GlassScriptPhysician profile
Ashley Schneider
NPI 1972153401
$6,392.40
in general payments reported to CMS, 2019-2025
29 companies · $1,104 in 2025
The $1,104 reported for 2025 was more than what 89% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $675 · 2022: $2,419 · 2023: $954 · 2024: $1,240 · 2025: $1,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,298.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,700.35 | 2021-2023 | Axonics |
| Dendreon Pharmaceuticals LLC | $1,308.49 | 2021-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $524.15 | 2022-2025 | |
| Janssen Biotech, INC. | $511.64 | 2021-2025 | Erleada, Rybrevant, Carvykti |
| Astellas Pharma US INC | $422.41 | 2021-2022 | |
| Pfizer INC. | $298.02 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $287.48 | 2021-2024 | Lynparza, Keytruda, Welireg |
| Abbvie INC. | $177.73 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $141.92 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $136.59 | 2022-2025 | Prolaris, Myrisk |
| Urovant Sciences INC | $108.51 | 2022 | |
| Urogen Pharma, INC. | $95.90 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $90.35 | 2022-2025 | |
| Medtronic, INC. | $71.07 | 2021 | |
| Procept Biorobotics Corporation | $65.66 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $59.08 | 2022-2024 | Xiaflex |
| Olympus America INC. | $57.53 | 2021-2025 | Itind System, Uretero-Reno Videoscope |
| Myovant Sciences INC. | $45.98 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $41.50 | 2023-2024 | Lynparza |
| Endo USA, INC. | $38.68 | 2024-2025 | Xiaflex, Aveed |
| Baxter Healthcare | $33.39 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Accord Healthcare, INC. | $31.97 | 2023 | |
| Teleflex LLC | $28.39 | 2022-2023 | Urolift |
| Convatec INC. | $26.35 | 2022 | |
| Blue Earth Diagnostics | $21.01 | 2024 | |
| Antares Pharma, INC. | $18.84 | 2022 | |
| Ethicon US, LLC | $18.22 | 2023 | Stratafix |
| Progenics Pharmaceuticals, INC. | $16.18 | 2024 | |
| Caris Mpi, INC. | $15.01 | 2025 | Mi Cancer Seek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.